Fig. 1.
Fig. 1. Effect of dexamethasone on the growth rate of normal human erythroid progenitor cells in serum-free medium. CD34+ cells were incubated in IDMEM supplemented with either 15% fetal calf serum (FCS, ▪) or 20% BIT-9500 (BIT, serum substitute, ▵). All cells received SCF (50 ng/mL). The medium concentration of Epo was maintained at 5 U/mL in FCS and BIT while it was reduced to 1 U/mL in BIT/Dexamethasone (Dexa)-medium (○). In addition, the latter medium contained 1 μmol/L of dexamethasone. For detailed composition of media see Materials and Methods. Starting at day 5, the cells were split 1:2 on each successive day, always adding ½ volume of fresh medium. Cells grown in the absence of dexamethasone entered terminal differentiation after day 8.

Effect of dexamethasone on the growth rate of normal human erythroid progenitor cells in serum-free medium. CD34+ cells were incubated in IDMEM supplemented with either 15% fetal calf serum (FCS, ▪) or 20% BIT-9500 (BIT, serum substitute, ▵). All cells received SCF (50 ng/mL). The medium concentration of Epo was maintained at 5 U/mL in FCS and BIT while it was reduced to 1 U/mL in BIT/Dexamethasone (Dexa)-medium (○). In addition, the latter medium contained 1 μmol/L of dexamethasone. For detailed composition of media see Materials and Methods. Starting at day 5, the cells were split 1:2 on each successive day, always adding ½ volume of fresh medium. Cells grown in the absence of dexamethasone entered terminal differentiation after day 8.

Close Modal

or Create an Account

Close Modal
Close Modal